INS and obesity due to melanocortin 4 receptor deficiency: Additionally, 67.3% of participants correctly identified the effect of obesity on insulin sensitivity, consistent with a 2022 study by Alharbi et al. [26] of 421 T2DM, 55.6% of whom were living with obesity.